Brief: Salarius Pharmaceuticals Reports Quarterly Loss Per Common Share Basic And Diluted Of $2.23

Decoy Therapeutics

11/05/2023 13:59

May 11 (Reuters) - Salarius Pharmaceuticals Inc
 SLRX.O :
    * SALARIUS PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES A BUSINESS UPDATE
    * SALARIUS PHARMACEUTICALS INC - QTRLY LOSS PER COMMON SHARE
-
BASIC AND DILUTED $2.23

Source text for Eikon:  ID:nGNX9xsB31 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))